• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

庞贝病中的牙龈增生:一例报告

Gingival overgrowth in Pompe disease: a case report.

作者信息

de Gijt J Pieter, van Capelle Carine I, Oosterhuis J Wolter, van der Ploeg Ans T, van der Wal Karel G H

机构信息

Department of Oral and Maxillofacial Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.

出版信息

J Oral Maxillofac Surg. 2011 Aug;69(8):2186-90. doi: 10.1016/j.joms.2011.03.070.

DOI:10.1016/j.joms.2011.03.070
PMID:21783002
Abstract

Pompe disease, or glycogen storage disease type 2, is a rare inheritable metabolic disease caused by a deficiency of the lysosomal enzyme acid α-glucosidase. Patients with the classic infantile form of Pompe disease present with symptoms during the first 3 months after birth, and most will die within their first year. Recently, enzyme replacement therapy (ERT) with recombinant human α-glucosidase became commercially available for Pompe disease. This is a case report of an 8-year-old girl with the infantile form of Pompe disease who is one of the longest survivors through ERT. The patient was tetraplegic when she started ERT. At age 3 years, she developed massive gingival overgrowth and could not close her mouth, prompting a reduction of the gingival overgrowth surgically. We expected that massive accumulation of glycogen would explain the gingival overgrowth. However, histopathology of the gingiva tissue showed marked glycogen accumulation in smooth muscle cells of the arteries, but the glycogen content in fibroblasts did not exceed that of control individuals. Further, there was an increase of immature collagen in the connective tissue, and signs of a mild chronic inflammation. We concluded that glycogen storage is not a direct causative factor of gingival overgrowth in our patient. Chronic inflammation, dryness of the gingiva, or even the minimal glycogen accumulation in the fibroblasts may have played a role.

摘要

庞贝病,即2型糖原贮积病,是一种罕见的遗传性代谢疾病,由溶酶体酶酸性α-葡萄糖苷酶缺乏引起。经典婴儿型庞贝病患者在出生后的前3个月出现症状,大多数患者会在1岁内死亡。最近,重组人α-葡萄糖苷酶的酶替代疗法(ERT)已在市场上用于治疗庞贝病。本文报告了一名8岁婴儿型庞贝病女孩的病例,她是接受ERT治疗后存活时间最长的患者之一。该患者开始接受ERT治疗时已四肢瘫痪。3岁时,她出现了严重的牙龈增生,无法闭嘴,促使通过手术减少牙龈增生。我们预期糖原的大量积累可以解释牙龈增生的原因。然而,牙龈组织的组织病理学显示动脉平滑肌细胞中有明显的糖原积累,但成纤维细胞中的糖原含量并未超过对照个体。此外,结缔组织中未成熟胶原蛋白增加,并有轻度慢性炎症迹象。我们得出结论,糖原贮积不是我们患者牙龈增生的直接致病因素。慢性炎症、牙龈干燥,甚至成纤维细胞中极少的糖原积累可能都起到了一定作用。

相似文献

1
Gingival overgrowth in Pompe disease: a case report.庞贝病中的牙龈增生:一例报告
J Oral Maxillofac Surg. 2011 Aug;69(8):2186-90. doi: 10.1016/j.joms.2011.03.070.
2
Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy.庞贝病(II型糖原贮积病):临床特征与酶替代疗法
Acta Neurol Belg. 2006 Jun;106(2):82-6.
3
Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers.替代庞贝病中的酸性α-葡萄糖苷酶:重组酶和转基因酶效力相当,但均不能完全清除II型肌纤维中的糖原。
Mol Ther. 2005 Jan;11(1):48-56. doi: 10.1016/j.ymthe.2004.09.017.
4
Correlation of acid alpha-glucosidase and glycogen content in skin fibroblasts with age of onset in Pompe disease.庞贝病中皮肤成纤维细胞酸性α-葡萄糖苷酶与糖原含量和发病年龄的相关性。
Clin Chim Acta. 2005 Nov;361(1-2):191-8. doi: 10.1016/j.cccn.2005.05.025.
5
[Treatment of Pompe's disease with recombinant enzymes].[用重组酶治疗庞贝氏病]
Verh K Acad Geneeskd Belg. 1998;60(4):347-57.
6
Late form of Pompe disease with glycogen storage in peripheral nerves axons.庞贝病的晚期形式,其糖原储存在周围神经轴突中。
J Neurol Sci. 2011 Feb 15;301(1-2):59-62. doi: 10.1016/j.jns.2010.10.031. Epub 2010 Nov 25.
7
Enzyme replacement therapy in classical infantile pompe disease: results of a ten-month follow-up study.经典型婴儿庞贝病的酶替代疗法:一项为期十个月的随访研究结果
Neuropediatrics. 2005 Feb;36(1):6-11. doi: 10.1055/s-2005-837543.
8
Effect of enzyme therapy in juvenile patients with Pompe disease: a three-year open-label study.酶疗法治疗青少年庞贝病患者的效果:一项为期三年的开放性研究。
Neuromuscul Disord. 2010 Dec;20(12):775-82. doi: 10.1016/j.nmd.2010.07.277.
9
Brain development in infantile-onset Pompe disease treated by enzyme replacement therapy.酶替代疗法治疗婴儿型庞贝病的脑发育情况
Pediatr Res. 2006 Sep;60(3):349-52. doi: 10.1203/01.pdr.0000233014.84318.4e. Epub 2006 Jul 20.
10
Complete correction of acid alpha-glucosidase deficiency in Pompe disease fibroblasts in vitro, and lysosomally targeted expression in neonatal rat cardiac and skeletal muscle.体外完全纠正庞贝病成纤维细胞中的酸性α-葡萄糖苷酶缺乏症,并在新生大鼠心肌和骨骼肌中进行溶酶体靶向表达。
Gene Ther. 1998 Apr;5(4):473-80. doi: 10.1038/sj.gt.3300609.

引用本文的文献

1
Three-dimensional tissue-engineered human skeletal muscle model of Pompe disease.庞贝氏病的三维组织工程化人骨骼肌模型。
Commun Biol. 2021 May 5;4(1):524. doi: 10.1038/s42003-021-02059-4.
2
Orofacial features and pediatric dentistry in the long-term management of Infantile Pompe Disease children.婴儿庞贝病患儿的口腔面部特征与儿童牙科:长期管理
Orphanet J Rare Dis. 2020 Nov 23;15(1):329. doi: 10.1186/s13023-020-01615-1.
3
Multisystem late onset Pompe disease (LOPD): an update on clinical aspects.多系统晚发型庞贝病(LOPD):临床方面的最新进展
Ann Transl Med. 2019 Jul;7(13):284. doi: 10.21037/atm.2019.07.24.
4
The impact of Pompe disease on smooth muscle: a review.庞贝病对平滑肌的影响:综述
J Smooth Muscle Res. 2018;54(0):100-118. doi: 10.1540/jsmr.54.100.
5
An 18-Month-Old Child with Infantile Pompe Disease: Oral Signs.一名患有婴儿型庞贝病的18个月大儿童:口腔体征。
Case Rep Dent. 2017;2017:5685941. doi: 10.1155/2017/5685941. Epub 2017 Mar 28.
6
Oral Health Status of Patients with Lysosomal Storage Diseases in Poland.波兰溶酶体贮积症患者的口腔健康状况
Int J Environ Res Public Health. 2017 Mar 9;14(3):281. doi: 10.3390/ijerph14030281.